127 related articles for article (PubMed ID: 30385725)
1. Arhgef12 drives IL17A-induced airway contractility and airway hyperresponsiveness in mice.
Fong V; Hsu A; Wu E; Looney AP; Ganesan P; Ren X; Sheppard D; Wicher SA; Thompson MA; Britt RD; Prakash YS; Bhattacharya M
JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385725
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β enhances Rho-kinase activity and contraction in airway smooth muscle via the nucleotide exchange factor ARHGEF1.
Shaifta Y; MacKay CE; Irechukwu N; O'Brien KA; Wright DB; Ward JPT; Knock GA
J Physiol; 2018 Jan; 596(1):47-66. PubMed ID: 29071730
[TBL] [Abstract][Full Text] [Related]
3. RhoA, a possible target for treatment of airway hyperresponsiveness in bronchial asthma.
Chiba Y; Matsusue K; Misawa M
J Pharmacol Sci; 2010; 114(3):239-47. PubMed ID: 20948164
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-17A directly acts on bronchial smooth muscle cells and augments the contractility.
Chiba Y; Tanoue G; Suto R; Suto W; Hanazaki M; Katayama H; Sakai H
Pharmacol Rep; 2017 Jun; 69(3):377-385. PubMed ID: 28267638
[TBL] [Abstract][Full Text] [Related]
5. IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction.
Kudo M; Melton AC; Chen C; Engler MB; Huang KE; Ren X; Wang Y; Bernstein X; Li JT; Atabai K; Huang X; Sheppard D
Nat Med; 2012 Mar; 18(4):547-54. PubMed ID: 22388091
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying the pathogenesis of hyper-contractility of bronchial smooth muscle in allergic asthma.
Sakai H; Suto W; Kai Y; Chiba Y
J Smooth Muscle Res; 2017; 53(0):37-47. PubMed ID: 28484126
[TBL] [Abstract][Full Text] [Related]
7. IQGAP1-dependent scaffold suppresses RhoA and inhibits airway smooth muscle contraction.
Bhattacharya M; Sundaram A; Kudo M; Farmer J; Ganesan P; Khalifeh-Soltani A; Arjomandi M; Atabai K; Huang X; Sheppard D
J Clin Invest; 2014 Nov; 124(11):4895-8. PubMed ID: 25271629
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein.
Chiba Y; Nakazawa S; Todoroki M; Shinozaki K; Sakai H; Misawa M
Am J Respir Cell Mol Biol; 2009 Feb; 40(2):159-67. PubMed ID: 18688040
[TBL] [Abstract][Full Text] [Related]
9. Orosomucoid-like 3 (ORMDL3) upregulates airway smooth muscle proliferation, contraction, and Ca
Chen J; Miller M; Unno H; Rosenthal P; Sanderson MJ; Broide DH
J Allergy Clin Immunol; 2018 Jul; 142(1):207-218.e6. PubMed ID: 28889952
[TBL] [Abstract][Full Text] [Related]
10. ArhGEF12 activates Rap1A and not RhoA in human dermal microvascular endothelial cells to reduce tumor necrosis factor-induced leak.
Khan A; Ni W; Baltazar T; Lopez-Giraldez F; Pober JS; Pierce RW
FASEB J; 2022 Apr; 36(4):e22254. PubMed ID: 35294066
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and their therapeutic potential for human diseases: MiR-133a and bronchial smooth muscle hyperresponsiveness in asthma.
Chiba Y; Misawa M
J Pharmacol Sci; 2010; 114(3):264-8. PubMed ID: 20953121
[TBL] [Abstract][Full Text] [Related]
12. Ontogenetic changes in contribution of calcium sensitization and calcium entry to blood pressure maintenance of Wistar-Kyoto and spontaneously hypertensive rats.
Behuliak M; Vavřínová A; Bencze M; Polgárová K; Ergang P; Kuneš J; Vaněčková I; Zicha J
J Hypertens; 2015 Dec; 33(12):2443-54. PubMed ID: 26418671
[TBL] [Abstract][Full Text] [Related]
13. RhoA/Rho-kinase as a therapeutic target in asthma.
Kume H
Curr Med Chem; 2008; 15(27):2876-85. PubMed ID: 18991642
[TBL] [Abstract][Full Text] [Related]
14. Involvement of RhoA-mediated Ca2+ sensitization in antigen-induced bronchial smooth muscle hyperresponsiveness in mice.
Chiba Y; Ueno A; Shinozaki K; Takeyama H; Nakazawa S; Sakai H; Misawa M
Respir Res; 2005 Jan; 6(1):4. PubMed ID: 15638941
[TBL] [Abstract][Full Text] [Related]
15. The role of RhoA-mediated Ca2+ sensitization of bronchial smooth muscle contraction in airway hyperresponsiveness.
Chiba Y; Misawa M
J Smooth Muscle Res; 2004 Oct; 40(4-5):155-67. PubMed ID: 15655303
[TBL] [Abstract][Full Text] [Related]
16. A novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice.
Chiba Y; Todoroki M; Nishida Y; Tanabe M; Misawa M
Am J Respir Cell Mol Biol; 2009 Nov; 41(5):516-24. PubMed ID: 19202006
[TBL] [Abstract][Full Text] [Related]
17. [Probable involvement of the augmented agonist-induced Ca2+ sensitization of airway smooth muscle contraction in the pathogenesis of airway hyperresponsiveness].
Chiba Y; Misawa M
Nihon Yakurigaku Zasshi; 1999 Sep; 114(3):185-90. PubMed ID: 10553582
[TBL] [Abstract][Full Text] [Related]
18. Targeting of Rac1 prevents bronchoconstriction and airway hyperresponsiveness.
André-Grégoire G; Dilasser F; Chesné J; Braza F; Magnan A; Loirand G; Sauzeau V
J Allergy Clin Immunol; 2018 Sep; 142(3):824-833.e3. PubMed ID: 29155102
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II activates the RhoA exchange factor Arhgef1 in humans.
Carbone ML; Brégeon J; Devos N; Chadeuf G; Blanchard A; Azizi M; Pacaud P; Jeunemaître X; Loirand G
Hypertension; 2015 Jun; 65(6):1273-8. PubMed ID: 25870189
[TBL] [Abstract][Full Text] [Related]
20. EphA4-mediated Rho activation via Vsm-RhoGEF expressed specifically in vascular smooth muscle cells.
Ogita H; Kunimoto S; Kamioka Y; Sawa H; Masuda M; Mochizuki N
Circ Res; 2003 Jul; 93(1):23-31. PubMed ID: 12775584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
